1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9802, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 69
Sponsor:
Protocol IDs: CRC-TU-HO3001, EU-93029
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: EORTC-26921
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9402, CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, NCT00002569, CE2
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-5942
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 69
Sponsor:
Protocol IDs: EORTC-26951, MRC-BR11, NCT00002840
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 10
Sponsor: NCI
Protocol IDs: COG-A9952, CCG-A9952, POG-A9952, CCG-9952, A9952, NCT00002944
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.015, MSKCC-98020, UCLA-HSPC-980105201, NCT00003293
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-UKLG-LY09, EU-98020, NCT00003421
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-97050, NCI-T97-0078, NCT00003564, T97-0078
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and under
Sponsor: NCI
Protocol IDs: POG-7621
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: BTSG-7501
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor:
Protocol IDs: BTSG-8001
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-340
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-75HD301, SEG-366, SEG-75HD0103
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-77HD320, SEG-77HD0103
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7406, MDAR-117
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7518, MDAR-24
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7703
|
